FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091309325> ?p ?o ?g. }

• W2091309325 endingPage "e76340" @default.
• W2091309325 startingPage "e76340" @default.
• W2091309325 abstract "Triple-negative breast cancer (TNBC), defined by the absence of an estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression, is associated with an early recurrence of disease and poor outcome. Furthermore, the majority of deaths in breast cancer patients are from metastases instead of from primary tumors. In this study, MCF-7 (an estrogen receptor-positive human breast cancer cell line), MDA-MB-231 (a human TNBC cell line) and 4T1 (a mouse TNBC cell line) were used to investigate the anti-cancer effects of ionizing radiation (IR) combined with suberoylanilide hydroxamic acid (SAHA, an inhibitor of histone deacetylase (HDAC)) and to determine the underlying mechanisms of these effects in vitro and in vivo. We also evaluated the ability of SAHA to inhibit the metastasis of 4T1 cells. We found that IR combined with SAHA showed increased therapeutic efficacy when compared with either treatment alone in MCF-7, MDA-MB-231 and 4T1 cells. Moreover, the combined treatment enhanced DNA damage through the inhibition of DNA repair proteins. The combined treatment was induced primarily through autophagy and ER stress. In an orthotopic breast cancer mouse model, the combination treatment showed a greater inhibition of tumor growth. In addition, SAHA inhibited the migration and invasion abilities of 4T1 cells and inhibited breast cancer cell migration by inhibiting the activity of MMP-9. In an in vivo experimental metastasis mouse model, SAHA significantly inhibited lung metastasis. SAHA not only enhances radiosensitivity but also suppresses lung metastasis in breast cancer. These novel findings suggest that SAHA alone or combined with IR could serve as a potential therapeutic strategy for breast cancer." @default.
• W2091309325 created "2016-06-24" @default.
• W2091309325 creator A5001081386 @default.
• W2091309325 creator A5007120531 @default.
• W2091309325 creator A5020937446 @default.
• W2091309325 creator A5034268536 @default.
• W2091309325 creator A5048520544 @default.
• W2091309325 creator A5056228804 @default.
• W2091309325 creator A5069581727 @default.
• W2091309325 creator A5089382018 @default.
• W2091309325 date "2013-10-10" @default.
• W2091309325 modified "2023-09-26" @default.
• W2091309325 title "Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer In Vitro and In Vivo" @default.
• W2091309325 cites W143763378 @default.
• W2091309325 cites W1967018540 @default.
• W2091309325 cites W1969106931 @default.
• W2091309325 cites W1969288365 @default.
• W2091309325 cites W1971941771 @default.
• W2091309325 cites W1978644939 @default.
• W2091309325 cites W1978664410 @default.
• W2091309325 cites W1978894503 @default.
• W2091309325 cites W1980947442 @default.
• W2091309325 cites W1985124617 @default.
• W2091309325 cites W1990953069 @default.
• W2091309325 cites W1998957807 @default.
• W2091309325 cites W2000368193 @default.
• W2091309325 cites W2002838864 @default.
• W2091309325 cites W2006995322 @default.
• W2091309325 cites W2009826707 @default.
• W2091309325 cites W2021172314 @default.
• W2091309325 cites W2029964395 @default.
• W2091309325 cites W2032365508 @default.
• W2091309325 cites W2041581075 @default.
• W2091309325 cites W2043526152 @default.
• W2091309325 cites W2044241702 @default.
• W2091309325 cites W2049521368 @default.
• W2091309325 cites W2055722507 @default.
• W2091309325 cites W2061261613 @default.
• W2091309325 cites W2066538173 @default.
• W2091309325 cites W2073741028 @default.
• W2091309325 cites W2074911710 @default.
• W2091309325 cites W2079569618 @default.
• W2091309325 cites W2083252086 @default.
• W2091309325 cites W2085376116 @default.
• W2091309325 cites W2087130345 @default.
• W2091309325 cites W2089198803 @default.
• W2091309325 cites W2089417788 @default.
• W2091309325 cites W2093048712 @default.
• W2091309325 cites W2094979409 @default.
• W2091309325 cites W2100662195 @default.
• W2091309325 cites W2102169774 @default.
• W2091309325 cites W2105095164 @default.
• W2091309325 cites W2108086395 @default.
• W2091309325 cites W2110787699 @default.
• W2091309325 cites W2110922204 @default.
• W2091309325 cites W2111208543 @default.
• W2091309325 cites W2126450883 @default.
• W2091309325 cites W2129913662 @default.
• W2091309325 cites W2135535991 @default.
• W2091309325 cites W2135619784 @default.
• W2091309325 cites W2145121495 @default.
• W2091309325 cites W2157285286 @default.
• W2091309325 cites W2158971210 @default.
• W2091309325 cites W2164943291 @default.
• W2091309325 cites W2170602872 @default.
• W2091309325 cites W2282035698 @default.
• W2091309325 doi "https://doi.org/10.1371/journal.pone.0076340" @default.
• W2091309325 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3794942" @default.
• W2091309325 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24130769" @default.
• W2091309325 hasPublicationYear "2013" @default.
• W2091309325 type Work @default.
• W2091309325 sameAs 2091309325 @default.
• W2091309325 citedByCount "69" @default.
• W2091309325 countsByYear W20913093252014 @default.
• W2091309325 countsByYear W20913093252015 @default.
• W2091309325 countsByYear W20913093252016 @default.
• W2091309325 countsByYear W20913093252017 @default.
• W2091309325 countsByYear W20913093252018 @default.
• W2091309325 countsByYear W20913093252019 @default.
• W2091309325 countsByYear W20913093252020 @default.
• W2091309325 countsByYear W20913093252021 @default.
• W2091309325 countsByYear W20913093252022 @default.
• W2091309325 countsByYear W20913093252023 @default.
• W2091309325 crossrefType "journal-article" @default.
• W2091309325 hasAuthorship W2091309325A5001081386 @default.
• W2091309325 hasAuthorship W2091309325A5007120531 @default.
• W2091309325 hasAuthorship W2091309325A5020937446 @default.
• W2091309325 hasAuthorship W2091309325A5034268536 @default.
• W2091309325 hasAuthorship W2091309325A5048520544 @default.
• W2091309325 hasAuthorship W2091309325A5056228804 @default.
• W2091309325 hasAuthorship W2091309325A5069581727 @default.
• W2091309325 hasAuthorship W2091309325A5089382018 @default.
• W2091309325 hasBestOaLocation W20913093251 @default.
• W2091309325 hasConcept C104317684 @default.
• W2091309325 hasConcept C121608353 @default.
• W2091309325 hasConcept C126322002 @default.
• W2091309325 hasConcept C150903083 @default.
• W2091309325 hasConcept C206684579 @default.

• next